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Objective: To observe the effect of Yinian Jiangya Yin (Decoction for lowering blood pressure to prolong life) 
on patients with early hypertension and its mechanism on the function of vascular endotheliocytes. Methods: 
The 79 patients with early primary hypertension belonging to the TCM syndrome of stagnation of phlegm 
and blood stasis in meridians and hyperactivity of the liver-yang were randomly divided into a treatment 
group of 40 patients treated with Yinian Jiangya Yin and a control group of 39 patients treated with Tianma 
Gouteng Yin (Decoction of Gastrodia and Uncaria). The changes in score of TCM syndrome and in blood 
pressure before and after treatment were observed in the two groups. The contents of nitrogen monoxide (NO) 
and endothelin (ET) in serum after treatment were determined. Results: There was a statistical difference 
(P<0.05) in score of TCM syndrome, effect of lowering blood pressure, and the contents of ET and NO in 
serum after treatment between the two groups. Conclusion: The effect of Yinian Jiangya Yin on improving 
TCM syndrome of patients with primary hypertension in early stage and on lowering blood pressure may be 
related to its regulating the imbalanced condition between ET and NO for restoring the function of 
endothelium-dependent vasodilation.    
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Dysfunction of endothelium-dependent vasodilation, 
a manifestation of early hypertension, causes the 
remolding of blood vessels and damage to target 
organs. In the late stage, the rise of blood pressure 
and damage to target organs aggravate lesion of 
vascular endothelium.1 Imbalance between endoth- 
elium-dependent systolic factor and diastolic factor 
decreases the release of nitrogen monoxide (NO) and 
increases the secretion of endothelin (ET). In the 
research, the authors used Yinian Jiangya Yin to treat 
primary hypertension in early stage and observed its 
influence on NO and ET in serum and its possible 
mechanism on primary hypertension in early stage.         
CLINICAL MATERIALS 
General Data 
The 79 outpatients aged 40–60 at the Hospital 
affiliated to Macao University of Science and 
Technology and the First Hospital affiliated to 
Guangzhou University of Chinese Medicine were 
randomly divided into a treatment group, 40 patients, 
17 males and 23 females, aged 51.70±4.53 on 
average, and a control group, 39 patients, 18 males 
and 21 females, aged 51.67±4.36 on average. There 
was no statistical difference (P>0.05) in sex and age 
between the two groups, hence compatible.1 
Diagnosis  
In reference to the standard for diagnosing grade Ⅰ 
hypertension (mild) stipulated by World Health 
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Organization International Society of Hypertension in 
1999,2 diagnostic standard in western medicine 
defines systolic blood pressure (SBP) as ≥140 mmHg 
and ≤159 mmHg, or diastolic blood pressure (DBP) 
as ≥90 mmHg and ≤99 mmHg, patients with SBP 
≥140 mmHg and ≤159 mmHg, or DBP ≥90 mmHg 
and ≤99 mmHg conform to the standard. 
In reference to the Principle for Guiding Clinical 
Research on New Chinese Drugs,3 standard for 
diagnosing TCM syndrome defines the main 
symptoms of stagnation of phlegm and blood stasis in 
meridians and hyperactivity of the liver-yang as 
dizziness, headache, heavy sensation in the head, 
oppressed feeling in the chest, obese body and loose 
stool, and the accompanying symptoms as palpitation, 
anorexia, insomnia, tinnitus, lumbago, dry mouth, 
pink or dark purple and enlarged tongue with tooth 
prints, greasy tongue coating and taut slippery or soft 
thready pulse. Patients with any two main symptoms 
or accompanying symptoms plus the tongue and 
pulse conditions conform to the standard.       
Inclusion 
Included are patients who conform to the above- 
mentioned diagnostic standard and without taking 
drugs for lowering blood pressure or stopped taking 
drugs for lowering blood pressure for 2 weeks. 
Exclusion 
Excluded are patients with coronary heart disease, 
diabetes, cerebrovascular disease, incomplete renal 
function, smoking history, allergic constitution or 
allergy to many drugs, patients who have taken part 
in other clinical experiment in recent 3 months, 
patients with bad obedience judged by researchers, 
and patients who can not strictly implement the 
experimental plan. 
METHODS 
Method of Treatment  
Single blind method (testees were in blind state) was 
used for clinical observation. In the treatment group, 
patients took Yinian Jiangya Yin (mainly consisting of 
Gou Teng (钩藤 Ramulus Uncariae cum Uncis) 20g 
(to be decocted later), Shi Jue Ming (石决明 Concha 
Haliotidis) 25g (to be decocted earlier), Cu Gui Jia 
(醋龟甲 Plastrum Testudinis) 20g (to be decocted 
earlier), Fa Ban Xia (法半夏 Rhizoma Pinelliae 
Praeparata) 10g, Chen Pi (陈皮 Pericarpium Citri 
Reticulatae) 8g, Chao Zhi Ke (炒枳壳 Fructus 
Aurantii) 12g, Huai Niu Xi ( 怀 牛 膝 Radix 
Achyranthis Bidentatae) 25g, Yi Mu Cao (益母草
Herba Leonuri) 15g, Sang Ji Sheng (桑寄生
RamulusLoranthi) 20g, and Zhi Shou Wu (制首乌
Radix Polygoni Multiflori) 20g). One dose was 
decocted with water into 200 ml every day. The 
decoction 100 ml was orally taken in the morning and 
in the evening respectively for 2 courses of treatment 
with 15 days as one course. Patients in the control 
group were treated with Tianma Gouteng Yin 
(consisting of Tian Ma (天麻Rhizoma Gastrodiae) 9g, 
Gou Teng (钩藤 Ramulus Uncariae cum Uncis) 12g 
(to be decocted later), Shi Jue Ming (石决明 Concha 
Haliotidis) 18g (to be decocted earlier), Zhi Zi (栀子
Fructus Gardeniae) 9g, Huang Qin (黄芩 Radix 
Scutellariae) 9g, Chuan Niu Xi (川牛膝 Radix 
Cyathulae) 12g, Du Zhong (杜仲 Cortex Eucommiae) 
9g, Yi Mu Cao (益母草 Herba Leonuri) 9g, Sang Ji 
Sheng (桑寄生 RamulusLoranthi) 9g, Ye Jiao Teng 
(夜交藤 Caulis Polygoni Multiflori) 9g, and Fu Shen 
(茯神 Poria cum Ligno Hospite) 9g).4 One dose was 
decocted with water into 200 ml every day. The 
decoction was orally taken with the same dosage, 
time and treatment course as in the treatment group.      
Indexes and Methods of Observation 
Clinical syndromes: Dizziness, headache, heavy 
sensation in the head, oppressed feeling in the chest, 
obese body, loose stool, palpitation, anorexia, 
insomnia, tinnitus, lumbago, and dry mouth are 
classified for scoring before and after treatment.3 No 
symptom is defined as score 0, mild symptom as 
score 1, moderate symptom as score 2 and severe 
symptom as score 3. 
Blood pressure: Blood pressure of right upper arm is 
determined with an automatic electronic sphyg- 
momanometer when patients take a sitting position. 
The determination begins after patients calmly take a 
rest for 15 minutes. StageⅠand stage Ⅳ of Korotkoff 
sounds is taken as SBP and DBP respectively. The 
determination is carried out once every 3 minutes for 
3 times and the average value of 3 determinations is 
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taken into the record. The readings of SBP and DBP 
before and after treatment are recorded. 
ET and NO: After treatment, venous blood 2 ml taken 
from a patient and evenly mixed with the anti- 
coagulant 10% EDTA2Na 30 µl and trasylol 40 µl in 
a tube is centrifugalized in a refrigerated centrifuge at 
4℃ and 3000 r/min for 10 minutes. Separated plasma 
is stored in a refrigerator at -20℃. ET is determined 
with a SN-695B radio-immunity γ-measuring ins- 
trument produced by Shanghai Rihuan Instrument 
Factory and a reagent kit produced by Beijing 
Pulweiye Biological Sci-tech Co. Ltd. Venous blood 
2 ml taken from a patient after treatment is put in a 
tube without the anti-coagulant for 20 minutes. 
Separated supernatant put in a centrifugal tube is 
centrifugalized at 3000 r/min for 10 minutes. Serum 
of upper layer is taken out and stored in a refrigerator 
at -20℃ to be determined. Method of determination 
with nitrate reductase is used to determine NO with a 
UV-754 spectrometer and a reagent kit produced by 
Nanjing Jiancheng Bio-engineering Institute.  
Safety: Under observation are possible adverse 
reactions in routine tests of blood, urine and stool as 
well as tests of hepatic and renal functions. 
Standard for Evaluation Therapeutic Effect 
According to the standard in reference, obvious effect 
means that SBP decreases by 20 mmHg or more to 
normality or DBP decreases by10 mmHg or more.3 
Effectiveness means that SBP decreases by less than 
20 mmHg but to normality or DBP decrease by less 
than 10 mmHg but to normality. Ineffectiveness 
means that blood pressure remains at the same level 
as before treatment or even increases. 
Statistic Method 
Statistical analysis is carried out with SPSS16.0 
software package. ( x ±s) is used to express 
measurement data. Independent Sample Test is used 
for comparison between the two groups. Enumeration 
data are compared with χ2 test. 
RESULT 
Comparison of Scores of TCM Syndrome Before 
and After Treatment in the Two Groups 
As shown in Table 1, the score of TCM syndrome 
after treatment was less than that before treatment in 
the two groups (P<0.05). There was a statistical 
difference (P<0.05) in reduction in the score of TCM 
syndrome between the two groups, indicating that the 
improvement of syndrome in the treatment group is 
better than that in the control group. 
Table 1. Comparison of scores of TCM syndrome 
before and after treatment in the two groups (score, 
x ±s) 




Treatment group 40 9.38±1.06 4.65±1.00*△ 
Control group 39 9.05±1.10 6.56±1.10* 
Note: *P<0.05 as compared to the datum before treatment in 
the same group; △P<0.05 as compared to the datum after 
treatment in the control group.  
Comparison of Blood Pressure Before and After 
Treatment in the Two Groups 
As shown in Table 2, there was no statistical 
difference (P>0.05) in SBP and DBP before treatment 
between the two groups, SBP and DBP after 
treatment were lower than those before treatment in 
the two groups (P<0.01), and there was a statistical 
difference (P<0.01) in SBP and DBP after treatment 
between the two groups, showing that the reduction 
in SBP and DBP in the treatment group is superior to 
that in the control group.    
Table 2. Comparison of SBP and DBP before and after treatment in the two groups (mmHg, x ±s) 
SBP DBP Group Cases 
Before treatment After treatment Before treatment After treatment 
Treatment group 40 155.65±3.167  145.25±3.319*△ 94.18±2.630  86.18±2.630*△ 
Control group 39 155.23±2.767 148.95±2.695* 93.72±2.305 88.79±2.285* 
Note: *P<0.01 as compared to the datum before treatment in the same group; △P<0.01 as compared to the datum after treatment in 
the control group.
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Comparison of the Effect on Lowering Blood 
Pressure between the Two Groups 
In the treatment group of 40 cases, the treatment was 
obviously effective on 8 cases, effective on 30 cases, 
and ineffective on 2 cases, with the total effective rate 
at 95.0%. In the control group of 39 cases, the 
treatment was effective on 34 cases and ineffective 
on 5 cases with the total effective rate at 87.2%. 
There was a statistical difference (P<0.05) in the total 
effective rate between the two groups, indicating that 
the effect in the treatment group is better than that in 
the control group.   
Comparison of ET and NO After Treatment 
between the Two Groups 
There was no statistical difference (P>0.05) in the 
contents of ET and NO before treatment between the 
two groups. As shown in Table 3, there was a 
statistical difference (P<0.05) in the contents of ET 
and NO after treatment between the two groups. The 
ET content was lower and the NO content was higher 
in the treatment group than those in the control 
group.   
Table 3. Comparison of ET and NO after treatment  
between the two groups ( x ±s) 
Group Cases ET (pg/ml) NO (µmol/L) 
Treatment group 40 39.09±17.38* 59.04±9.80* 
Control group 39 47.01±14.83 53.91±10.83 
Note: *P<0.05 as compared to the datum in the control group.  
Adverse Reaction 
No abnormality was found in the examinations of 
hepatic and renal functions as well as in the routine 
tests of blood, urine and stool of the 79 patients after 
treatment. 
DISCUSSION 
According to TCM theory, the authors hold that 
tendons not only link to muscles and joints but also 
attach to blood vessels to regulate vascular 
expansion and contraction. Because the liver 
governs tendons, vascular expansion and contraction 
are closely related to hepatic function. The main 
pathogenesis of primary hypertension is that hepatic 
dysfunction can cause disordered circulation of qi 
and blood and abnormal expansion and contraction 
of blood vessels.5 In the area of Guangzhou and 
Macao with sub-tropic climate, where people are 
found of cold tea and seafood and live a life with 
quick rhythm, early hypertension mainly belongs to 
the stagnation of phlegm and blood stasis in 
meridians and hyperactivity of the liver-yang in 
TCM syndromes. In the recipe of Yinian Jiangya Yin 
prescribed according to TCM pathological chara- 
cteristics of early hypertension in the area, Gou 
Teng (钩藤 Ramulus Uncariae cum Uncis), Shi Jue 
Ming (石决明 Concha Haliotidis) and Cu Gui Jia 
(醋龟甲 Plastrum Testudinis) can calm the liver to 
suppress its yang hyperactivity; Fa Ban Xia (法半夏
Rhizoma Pinelliae Praeparata), Chen Pi (陈皮
Pericarpium Citri Reticulatae) and Chao Zhi Ke (炒
枳壳 Fructus Aurantii) can dissolve damp, remove 
phlegm and promote qi-circulation to regulate the 
stomach; Yi Mu Cao (益母草 Herba Leonuri) can 
promote blood circulation and induce diuresis to 
clear meridians; Huai Niu Xi (怀牛膝 Radix 
Achyranthis Bidentatae), Sang Ji Sheng (桑寄生
RamulusLoranthi) and Zhi Shou Wu (制首乌 Radix 
Polygoni Multiflori) can nourish the liver and 
kidney to treat the Ben-root. All ingredients of the 
recipe are used to jointly calm the liver, nourish 
tendons, remove phlegm and clear meridians. The 
result of the research showed that the effect of 
Yinian Jiangya Yin on improving TCM syndrome of 
patients with early hypertension and lowering blood 
pressure in the treatment group was better than that 
in the control group. 
The medical circle has generally recognized the 
important role played by dysfunction of vascular 
endotheliocytes in causing hypertension and its 
pathological change. There is a negative feedback 
regulation between ET and NO, a pair of vascular 
systolic and diastolic factors, synthesized and 
released by vascular endotheliocytes in the phy- 
siological condition. The synthesis and release of ET 
and NO are in dynamic balance to jointly regulate 
vascular tension.6,7 In hypertension, the balance is 
broken, making ET increase and NO decrease. The 
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result of the research showed that after treatment, 
decrease in ET and increase in NO were more 
obvious in the treatment group than those in the 
control group, indicating that with its effect on 
lowering the active ingredient for contracting blood 
vessels and increasing the active ingredient for 
expanding blood vessels, Yinian Jiangya Yin can 
regulate the imbalance between ET and No of 
patients with early hypertension. To sum up, the 
effect of Yinian Jiangya Yin on improving syndrome 
and lowering blood pressure may be related to its 
regulating the imbalanced ET and NO for restoring 
the function of endothelium-dependent vasodilation.   
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